PERCEVAL ™

First Patient Enrolled in the PERSIST-AVR Trial at CHU Brabois, University of Lorraine, Nancy – France

Discover more

MEMO 3D RECHORD

LivaNova receives regulatory approval in Canada for its innovative Memo 3D ReChord annuloplasty ring for mitral valve repair

Discover more

PERCEVAL

LivaNova announces the first U.S. implant of Perceval, the only sutureless valve for aortic valve replacement surgery

Discover more

SOLO SMART

LivaNova receives regulatory approval in Japan for the Solo Smart stentless tissue aortic valve

Discover more

CROWN PRT ™

LivaNova announces FDA approval of stented heart valve CROWN PRT ™ for aortic valve disease

Discover more

KORA 250 now approved in Japan

World’s smallest full body MRI conditional pacing system with extended longevity and proprietary technologies designed to improve patient outcome

Discover more

Latest News

Dec 1, 2016

LivaNova PLC to Present at the Berenberg European Conference

READ MORE

Nov 11, 2016

LivaNova PLC to Present at the Jefferies and Piper Jaffray Conferences

READ MORE

Nov 10, 2016

VNS Therapy is Proven Treatment Option, but Treatment Gap Remains

READ MORE

Nov 2, 2016

LivaNova Reports Third Quarter 2016 Results

READ MORE

Nov 2, 2016

LivaNova PLC Announces CEO Transition: Damien McDonald to Succeed André-Michel Ballester

READ MORE

In the Spotlight

Version unknown | Revision 92986 | Status unstable | SessionId 8740F0951F9194A45ECA475040A23651.jvm0